Logo
The Klinikum rechts der Isar university hospital of the Technical University of Munich is a major European center of medical care and education. With over 1.161 beds and almost 5.500 employees, we treat some 300.000 patients per year with state-of-the art care.

Position for a Postdoc available in the field of
“Molecular imaging and radionuclide therapy in prostate cancer“

Description:
The Technische Universität München (TUM) is seeking applications from highly motivated candidates for a Postdoc position in molecular imaging and therapy using novel probes. The candidates will work in the DFG-funded Collaborative Research Center (SFB 824) entitled “Imaging for Selection, Monitoring and Individualization of Cancer Therapies“. The specific subproject in the SFB 824 is focussed on therapy assessment in prostate cancer using novel probes for PET-imaging and radionuclide therapy.
The candidate will be involved in applying established and newly developed nuclear probes to preclinical and clinical problems. The project is embedded in current advances in imaging and therapy of prostate cancer conducted at TUM. The project will be conducted in close collaboration with the Chair of Pharmaceutical Radiochemistry and the Department of Urology. The candidate will be integrated in a team of experienced scientists from TUM Nuclear Medicine (PD Dr. Matthias Eiber), TUM Chair of Radiochemistry (Prof. Dr. Hans-Jürgen Wester) and TUM Urology (PD Dr. Tobias Maurer).

Qualifications:
  • We accept applications from candidates having a PhD with excellent degrees in biology or chemistry
  • Practical experience in cell culture, flow cytometry and animal research including preclinical imaging is required (e.g. FELASA B or equivalent skills)
  • Experience in application of radioactive probes and analysing image data is important. The candidate is expected to supervise technical assistants and students
Our offer:
  • Postdoc candidates will be employed by TUM (full position TV-L E13)
  • The position is initially limited to the current funding period of the SF824 (project ends on June 30th, 2021)
  • The TUM provides access to excellent infrastructure for conducting cutting-edge research in the field of molecular imaging (e.g. TranslaTUM as core facility for preclinical research, preclinical PET/CT and PET/MRI, state-of-the art radiochemistry)
Application Details:
Applications should include curriculum vita, certificates and transcript of MA or doctoral degree, summary of previous work, letter of motivation, two key publications and two references. We give priority to severely disabled applicants with essentially equal qualifications. Please send your application in one PDF-document to Bewerbung.Nuklearmedizin@mri.tum.de no later than April 1st, 2018.

Contact:
PD Dr. Matthias Eiber
Phone: +49 89 4140 4549
Department of Nuclear Medicine, Klinikum rechts der Isar der TU München
Ismaninger Straße 22, 81675 Munich, Germany

Bewerbungsschluss: 01.04.2018